Q301--Long -Term Specialized Reference Laboratory for Measurable Residual Disease (MRD) detection in hematologic malignancies - Base Plus 4 9/1/26-8/31/31

The VA Portland Healthcare System (VHAPORHCS) Pathology & Laboratory Medicine Service Department is seeking a specialized reference laboratory for Measurable Residual Disease (MRD) detection in hematologic malignancies. The laboratory will provide continued access to specialized testing for MRD detection, which is a powerful diagnostic and prognostic tool that quantifies the presence of residual cancer cells during and after treatment in patients with multiple myeloma, B-cell acute lymphoblastic leukemia (B-ALL), and chronic lymphocytic leukemia (CLL). The key aspects of this opportunity include: • Specialized testing for MRD detection in hematologic malignancies • Continued access to specialized testing • Powerful diagnostic and prognostic tool for patients with multiple myeloma, B-ALL, and CLL • The laboratory will provide testing services for the VA Portland Healthcare System